Literature DB >> 12530441

Healthcare ethics: a patient-centered decision model.

A R Oddo1.   

Abstract

A common financial model used in business decisions is the cost/benefit comparison. The costs of a proposed project are compared with the benefits, and if the benefits outweigh the costs, the project is accepted; if the costs exceed the benefits, the project is rejected. This model is applicable when tangible costs and benefits can be reasonably measured in monetary units. However, it is difficult to consider intangible factors in this model because intangible factors cannot be readily quantified in money. While some might argue that the financial model should not apply to healthcare decisions, the fact is that costs do enter into the picture. People may decide to forego needed healthcare because they cannot afford it. Healthcare providers may make choices based in part on the costs of diagnosis and treatment, rather than solely on medical information and what is best for the patient. Should financial issues enter into healthcare decisions--decisions about human health and well being? If so, how should the costs and benefits be measured and evaluated? What are some ethical issues and dilemmas involved in such decisions. This paper addresses ethical dilemmas and financial issues in healthcare. A healthcare decision model, which considers medical information, financial information, as well as ethical and other intangible factors, is proposed.

Entities:  

Keywords:  Analytical Approach; Health Care and Public Health

Mesh:

Year:  2001        PMID: 12530441     DOI: 10.1023/a:1006407312383

Source DB:  PubMed          Journal:  J Bus Ethics        ISSN: 0167-4544


  2 in total

1.  Healthcare resource allocation decisions affecting uninsured services.

Authors:  Krista Lyn Harrison; Holly A Taylor
Journal:  J Health Organ Manag       Date:  2016-11-21

2.  Assessing a group of physicians' ethical sensitivity in Turkey.

Authors:  M Cetin; M Cimen
Journal:  Iran J Public Health       Date:  2011-09-30       Impact factor: 1.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.